Classifications

• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
  • C12N9/10—Transferases (2.)
  • C12N9/1025—Acyltransferases (2.3)
  • C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
  • C12N15/09—Recombinant DNA-technology
  • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
  • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
  • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
  • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
  • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
  • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
  • C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition

Definitions

• the invention relates to alteration of oil content in plants.
• Triacylglycerols produced in plant tissues are a significant source of fatty acids in the human diet. Diets rich in animal fat appear to promote maladies such as heart disease in humans. The ability to modulate triacyl glycerol synthesis in plants could allow for production of fatty acid compositions that are more beneficial for humans or more efficiently synthesized by the plant. Cloning and characterization of plant genes encoding enzymes involved in triacylglycerol synthesis and metabolism represents a major advance toward controlling triacylglycerol synthesis in plants.
• a new plant acyltransferase gene from Brassica napus has been cloned and characterized.
• the protein encoded by this gene is involved in triacylglycerol synthesis.
• Partial DNA sequences of the B. napus gene confirm that it is related to an Arabidopsis thaliana putative acyltransferase gene.
• Antisense expression of the B. napus sequence decreases total oil content.
• the invention features an isolated nucleic acid having at least 80% (e.g., 85%, 90%, or 99%) sequence identity to the nucleotide sequence of SEQ ID NO:3, or to a fragment of the nucleotide sequence of SEQ ID NO:3, the fragment being at least 15 nucleotides in length.
• An isolated nucleic acid having at least 80% (e.g., 85%, 90%, or 99%) sequence identity to the nucleotide sequence of SEQ ID NO:4, or to a fragment of the nucleotide sequence of SEQ ID NO:4, the fragment being at least 15 nucleotides in length is also featured.
• the invention features an isolated nucleic acid that includes a first and second region, the first region having at least 80% sequence identity to the nucleotide sequence of SEQ ID NO:3 and the second region having at least 80% sequence identity to the nucleotide sequence of SEQ ID NO:4.
• the nucleic acid can encode a diacylglycerol acyltransferase polypeptide.
• the first and second regions can be separated by approximately 600 nucleotides.
• the nucleic acid can be the insert of pMB143.
• An expression vector including the nucleic acid operably linked to an expression control element also is featured.
• the nucleic acid can be operably linked in antisense orientation.
• the invention features a transgenic plant and progeny thereof that include an exogenous nucleic acid encoding a diacylglycerol acyltransferase polypeptide operably linked to a regulatory element, and seed produced by such plants.
• the nucleic acid can include a first and second region, the first region having at least 80% sequence identity to the nucleotide sequence of SEQ ID NO:3, the second region having at least 80% sequence identity to the nucleotide sequence of SEQ ID NO:4.
• the transgenic plant can produce seeds that exhibit a statistically significantly altered oil content as compared to seeds produced by a corresponding plant lacking the nucleic acid encoding the diacylglycerol acyltransferase polypeptide.
• the plant can be a soybean plant or a Brassica plant.
• the invention also features a nucleic acid that includes the nucleotide sequence of SEQ ID NO:3 or SEQ ID NO:4 or the nucleotide sequence exactly complementary to SEQ ID NO:3 or SEQ ID NO:4.
• the nucleic acid also can include the RNA equivalent of the nucleotide sequence of SEQ ID NO:3 or SEQ ID NO:4, or an RNA equivalent that is exactly complementary to the nucleotide sequence of SEQ ID NO:3 or SEQ ID NO:4.
• the nucleotide sequences of SEQ ID NO:3 and SEQ ID NO:4 are partial sequences of the new B. napus gene.
• the invention features a nucleic acid that (1) hybridizes under stringent conditions to a DNA molecule consisting of the nucleotide sequence of SEQ ID NO:3 or SEQ ID NO:4, and (2) encodes a plant acyltransferase.
• the invention includes a nucleic acid (1 ) having a nucleotide sequence which is at least 80% (e.g., at least 82, 85, 90, 92, 95, 98, or 99%) identical to the nucleotide sequence of SEQ ID NO:3 or SEQ ID NO:4, and (2) encoding a plant acyltransferase.
• the term "stringent conditions” means hybridization at 42°C in the presence of 50% formamide; a first wash at 65°C with 2X SSC containing 1% SDS; followed by a second wash at 65°C with 0.1 X SSC.
• the nucleotide sequence fragments described below can be used to hybridize against cD A or genomic DNA libraries from a variety of sources to clone genes related to the B. napus acyltransferase gene.
• the sequence fragments can be used to design additional primers for further sequencing of the B. napus gene or for PCR amplification of portions of the B. napus gene.
• Figure 1 is a schematic of a construct containing the acyltransferase. Restriction sites are marked.
• Figure 2 is a schematic of a construct containing the acyltransferase in antisense orientation. Restriction sites are marked.
• Triacylglycerols are synthesized by the sequential transfer of acyl chains to the glycerol backbone by a series of enzymes in the Kennedy pathway (glycerol-3-phosphate acyltransferase, lysophosphatidic acid acyltransferase, and diacylglycerol acyltransferase). See, Topfer et al., Science. 1995, 268:681-686. Diacylglycerol can be used to form TAGs or membrane glycerolipids, and is the substrate for diacylglycerol acyltransferase (DAGAT, E.C. 2.3.1.20).
• DAAT diacylglycerol acyltransferase
• DAGAT transfers a third acyl chain to diacylglycerol, forming a TAG, and is the only enzyme unique to TAG synthesis in the Kennedy pathway.
• the reaction catalyzed by DAGAT represents a key branchpoint in TAG synthesis.
• a 1.4 kB gene that encodes DAGAT has been identified from Brassica and can be used to alter total oil content in plants.
• the invention features isolated nucleic acids having at least 80% sequence identity, e.g., 85%, 90%, 95%, or 99% sequence identity, to the nucleic acid of SEQ ID NO:3 or SEQ ID NO:4, or fragments of the nucleic acid of SEQ ID NO:3 or 4 that are at least about 15 nucleotides (nt) in length (e.g., at least 18, 20, 22, 24, 26, 28, or 30 nt).
• the nucleic acid includes a first region having at least 80%) sequence identity to the nucleotide sequence of SEQ ID NO:3 and a second region having at least 80% sequence identity to the nucleotide sequence of SEQ ID NO:4.
• the first and second regions can be separated by about 590 to about 700 nucleotides, e.g., about 600 nucleotides.
• percent sequence identity is calculated by determining the number of matched positions in aligned nucleic acid sequences, dividing the number of matched positions by the total number of aligned nucleotides, and multiplying by 100.
• a matched position refers to a position in which identical nucleotides occur at the same position in aligned nucleic acid sequences.
• the total number of aligned nucleotides refers to the number of nucleotides from SEQ ID NO:3 or NO:4 that are being aligned.
• Nucleic acid sequences can be aligned by the Clustal algorithm of MEGALIGN® (DNASTAR, Madison, WI, 1997) sequence alignment software. In this method, sequences are grouped into clusters by examining the distances between all pairs.
• Isolated nucleic acid molecules of the invention can be produced by standard techniques.
• isolated refers to a sequence corresponding to part or all of a gene encoding a DAGAT polypeptide, but free of sequences that normally flank one or both sides of the wild-type gene in a plant genome.
• polypeptide refers to a chain of least eight amino acids.
• An isolated nucleic acid can be, for example, a DNA molecule, provided one of the nucleic acid sequences normally found immediately flanking that DNA molecule in a naturally-occurring genome is removed or absent.
• an isolated nucleic acid includes, without limitation, a DNA molecule that exists as a separate molecule (e.g., a cDNA or genomic DNA fragment produced by PCR or restriction endonuclease treatment) independent of other sequences as well as recombinant DNA that is incorporated into a vector, an autonomously replicating plasmid, a virus (e.g., a retrovirus, adenovirus, or herpes virus), or into the genomic DNA of a prokaryote or eukaryote.
• an isolated nucleic acid can include a recombinant DNA molecule that is part of a hybrid or fusion nucleic acid.
• a nucleic acid existing among hundreds to millions of other nucleic acids within, for example, cDNA libraries or genomic libraries, or gel slices containing a genomic DNA restriction digest, is not to be considered an isolated nucleic acid.
• Isolated nucleic acid molecules are at least about 15 nucleotides in length.
• the nucleic acid molecule can be about 20 to 35, 40-50, 50-100, or greater than 150 nucleotides in length, e.g., 200-300, 300-500, 500-1000, or 1 100-1500 nucleotides in length.
• Such fragments, whether encoding a polypeptide or not, can be used as probes, primers, and diagnostic reagents.
• the isolated nucleic acid molecules encode a full-length DAGAT polypeptide.
• Nucleic acid molecules can be DNA or RNA, linear or circular, and in sense or antisense orientation.
• the nucleic acid molecules also can be complementary to the nucleotide sequences of SEQ ID NO:3 or SEQ ID NO:4.
• a nucleic acid encoding a DAGAT polypeptide may or may not contain introns within the coding sequence.
• PCR Polymerase chain reaction
• Nucleic acids encoding DAGAT polypeptides also can be produced by chemical synthesis, either as a single nucleic acid molecule or as a series of oligonucleotides. For example, one or more pairs of long oligonucleotides (e.g., >100 nucleotides) can be synthesized that contain the desired sequence, with each pair containing a short segment of complementarity (e.g., about 15 nucleotides) such that a duplex is formed when the oligonucleotide pair is annealed. DNA polymerase is used to extend the oligonucleotides, resulting in a double-stranded nucleic acid molecule per oligonucleotide pair, which then can be ligated into a vector.
• a short segment of complementarity e.g., about 15 nucleotides
• nucleic acids will encode a polypeptide having a particular DAGAT amino acid sequence.
• the degeneracy of the genetic code is well known in the art, i.e., many amino acids are encoded by more than one nucleotide codon.
• certain amino acid substitutions can be made within polypeptide sequences without affecting the function of the polypeptide.
• Conservative amino acid substitutions or substitutions of similar amino acids often are tolerated without affecting polypeptide function.
• Similar amino acids can be those that are similar in size and/or charge properties. Similarity between amino acids has been assessed in the art. For example, Dayhoff et al. (1978) in Atlas of Protein Sequence and Structure, Vol. 5, Suppl. 3, pp. 345-352, provides frequency tables for amino acid substitutions that can be employed as a measure of amino acid similarity.
• the invention features transgenic plants that have altered total oil content, i.e., increased or decreased oil content.
• Suitable plant species include, for example, Brassica spp. such as B. napus, B. campestris, B.juncea, and B. rapa (canola-type and high erucic acid rapeseed), soybean, sunflower, castor bean, safflower, crambe, palm, coconut, corn, cottonseed, olive, peanut, flax, and sesame.
• Canola, soy, sunflower, and safflower plants having increased oil content are particularly useful.
• Table 1 provides relative percent oil and protein content on a dry weight basis (unless indicated otherwise) of suitable oilseed plants.
• the present invention describes a novel method of making transgenic plants that produce seeds with a statistically significant alteration in oil content.
• "statistically significant” refers to a p-value of less than 0.05, e.g., a p-value of less than 0.025 or a p-value of less than 0.01, using an appropriate measure of statistical significance, e.g., a one-tailed two sample t-test.
• plants can be produced that exhibit an altered oil content in their seeds.
• the altered oil content is statistically significant relative to the oil content of unmodified seeds.
• Plants produced by the method of the present invention can produce seeds having an increase in oil of from about 1% to about 25% over the oil content in seeds produced by unmodified control plants.
• the increase in oil content for plants described herein can be from about 2% to about 20%, from about 4% to about 15%, from about 5% to about 10%, or from about 10% to about 20%, relative to unmodified plants.
• a plant described herein may be used as a parent to develop a plant line, or may itself be a member of a plant line, i.e., it is one of a group of plants that display little or no genetic variation between individuals for total oil content.
• Such lines can be created by several generations of self-pollination and selection, or vegetative propagation from a single parent using tissue or cell culture techniques known in the art. Additional means of breeding plant lines from a parent plant are known in the art.
• plants of the invention can be obtained by introducing at least one exogenous nucleic acid encoding a DAGAT polypeptide into plant cells.
• exogenous refers to a nucleic acid that is introduced into the plant. Exogenous nucleic acids include those that naturally occur in the plant and have been introduced to provide one or more additional copies, as well as nucleic acids that do not naturally occur in the plant.
• a nucleic acid construct containing a nucleic acid encoding a DAGAT polypeptide is introduced into a plant cell. Seeds produced by a transgenic plant can be grown and selfed (or outcrossed and selfed) to obtain plants homozygous for the construct.
• Transgenic plants can be entered into a breeding program, e.g., to increase seed, to introgress the novel construct into other lines or species, or for further selection of other desirable traits.
• transgenic plants can be obtained by vegetative propagation of a transformed plant cell, for those species amenable to such techniques.
• Progeny of a transgenic plant are included within the scope of the invention, provided that such progeny exhibit altered oil content.
• Progeny of an instant plant include, for example, seeds formed on Fi, F 2 , F 3 , and subsequent generation plants, or seeds formed on BCi, BC 2 , BC 3 , and subsequent generation plants.
• Transgenic techniques for use in the invention include, without limitation, Agrobacterium-mediated transformation, electroporation, and particle gun transformation.
• Illustrative examples of transformation techniques are described in WO 99/43202 and U.S. Patent 5,204,253 (particle gun) and U.S. Patent 5,188,958 (Agro bacterium). Transformation methods utilizing the Ti and Ri plasmids of Agrobacterium spp. typically use binary type vectors. Walkerpeach, C. et al., in Plant Molecular Biology Manual, S. Gelvin and R. Schilperoort, eds., Kluwer Dordrecht, Cl :l-19 (1994). If cell or tissue cultures are used as the recipient tissue for transformation, plants can be regenerated from transformed cultures by techniques known to those skilled in the art. In addition, various plant species can be transformed using the pollen tube pathway technique.
• Nucleic acid constructs suitable for producing transgenic plants of the invention include a nucleic acid encoding a DAGAT polypeptide operably linked to a regulatory element such as a promoter. Standard molecular biology techniques can be used to generate nucleic acid constructs. To increase oil content in plants, the nucleic acid encoding a DAGAT polypeptide is operably linked to the regulatory element in sense orientation. Suitable promoters can be constitutive or inducible, and can be seed-specific.
• constitutive promoter refers to a promoter that facilitates the expression of a nucleic acid molecule without significant tissue- or temporal- specificity.
• An inducible promoter may be considered to be a "constitutive promoter", provided that once induced, expression of the nucleic acid molecule is relatively constant or uniform without significant tissue- or temporal-specificity. Suitable promoters are known (e.g., Weising et al., Ann. Rev. Genetics 22:421-478 (1988)).
• promoters suitable for use herein regulatory sequences from fatty acid desaturase genes (e.g., Brassica fadlD or fad2F, see WO 00/07430); alcohol dehydrogenase promoter from corn; light inducible promoters such as the ribulose bisphosphate carboxylase (Rubisco) small subunit gene promoters from a variety of species; major chlorophyll a/b binding protein gene promoters; the 19S promoter of cauliflower mosaic virus (CaMV); as well as synthetic or other natural promoters that are either inducible or constitutive.
• regulatory sequences from fatty acid desaturase genes e.g., Brassica fadlD or fad2F, see WO 00/07430
• alcohol dehydrogenase promoter from corn
• light inducible promoters such as the ribulose bisphosphate carboxylase (Rubisco) small subunit gene promoters from a variety of species
• regulatory sequences are seed-specific, i.e., the particular gene product is preferentially expressed in developing seeds and expressed at low levels or not at all in the remaining tissues of the plant.
• seed-specific promoters include napin, phaseolin, oleosin, and cruciferin promoters.
• Additional regulatory elements may be useful in the nucleic acid constructs of the present invention, including, but not limited to, polyadenylation sequences, enhancers, introns, and the like. Such elements may not be necessary for expression of a DAGAT polypeptide, although they may increase expression by affecting transcription, stability of the mRNA, translational efficiency, or the like. Such elements can be included in a nucleic acid construct as desired to obtain optimal expression of the acyltransferase nucleic acid in the host cell(s). Sufficient expression, however, may sometimes be obtained without such additional elements.
• a reference describing specific regulatory elements is Weising et al., Ann. Rev. Genetics 22:421-478 (1988).
• a feature of the invention is that DAGAT activity can be reduced by gene silencing, antisense, ribozymes, cosuppression, or mutagenesis techniques, resulting in a decrease in oil content.
• Gene silencing techniques such as that described in WO 98/36083 are useful.
• Antisense RNA has been used to inhibit plant target genes in a tissue-specific manner. See, for example, U.S. Patent Nos. 5,453,566, 5,356,799, and 5,530,192.
• Antisense nucleic acid constructs include a partial or a full-length coding sequence operably linked to at least one suitable regulatory sequence in antisense orientation.
• DAGAT also can be inhibited by ribozyme molecules designed to cleave DAGAT mRNA transcripts. While various ribozymes that cleave mRNA at site-specific recognition sequences can be used to destroy DAGAT mRNAs, hammerhead ribozymes are particularly useful. Hammerhead ribozymes cleave mRNAs at locations dictated by flanking regions that form complementary base pairs with the target mRNA. The sole requirement is that the target RNA contain a 5'-UG- 3' nucleotide sequence. The construction and production of hammerhead ribozymes is well known in the art. See, for example, U.S. Patent No. 5,254,678.
• RNA endoribonucleases such as the one that occurs naturally in Tetrahymena thermophila, and which have been described extensively by Cech and collaborators also are useful.
• Mutagenesis can also be used to reduce acytltransferase activity in plants.
• Mutagenic agents can be used to induce random genetic mutations within a population of seeds or regenerable plant tissue. Suitable mutagenic agents include, for example, ethyl methyl sulfonate, methyl N-nitrosoguanidine, ethidium bromide, diepoxybutane, x-rays, UV rays, and other mutagens known in the art.
• the treated population, or a subsequent generation of that population is screened for reduced oil content or reduced DAGAT activity that results from the mutation.
• Mutations can be in any portion of a gene, including the coding region, introns, and regulatory elements, that render the resulting gene product non-functional or with reduced activity. Suitable types of mutations include, for example, insertions or deletions of nucleotides, and transitions or transversions in the wild-type coding sequence. Such mutations can lead to deletion or insertion of amino acids, and conservative or non-conservative amino acid substitutions in the corresponding gene product.
• Oils Techniques that are routinely practiced in the art can be used to extract, process, and analyze the oils produced by plants of the instant invention.
• plant seeds are cooked, pressed, and extracted to produce crude oil, which is then degummed, refined, bleached, and deodorized.
• techniques for crushing seed are known in the art.
• soybean seeds can be tempered by spraying them with water to raise the moisture content to, e.g., 8.5%, and flaked using a smooth roller with a gap setting of 0.23 to 0.27 mm.
• water may not be added prior to crushing.
• Application of heat deactivates enzymes, facilitates further cell rupturing, coalesces the oil droplets, and agglomerates protein particles, all of which facilitate the extraction process.
• the majority of the seed oil can be released by passage through a screw press. Cakes expelled from the screw press are then solvent extracted, e.g., with hexane, using a heat traced column.
• crude oil produced by the pressing operation can be passed through a settling tank with a slotted wire drainage top to remove the solids that are expressed with the oil during the pressing operation.
• the clarified oil can be passed through a plate and frame filter to remove any remaining fine solid particles. If desired, the oil recovered from the extraction process can be combined with the clarified oil to produce a blended crude oil.
• Degumming can be performed by addition of concentrated phosphoric acid to the crude oil to convert non-hydratable phosphatides to a hydratable form, and to chelate minor metals that are present. Gum is separated from the oil by centrifugation. The oil can be refined by addition of a sufficient amount of a sodium hydroxide solution to titrate all of the fatty acids and removing the soaps thus formed.
• Deodorization can be performed by heating the oil to 500°F (260°C) under vacuum, and slowly introducing steam into the oil at a rate of about 0.1 ml/minute/100 ml of oil. After about 30 minutes of sparging, the oil is allowed to cool under vacuum. The oil is typically transferred to a glass container and flushed with argon before being stored under refrigeration. If the amount of oil is limited, the oil can be placed under vacuum, e.g., in a Parr reactor and heated to 500°F for the same length of time that it would have been deodorized. This treatment improves the color of the oil and removes a majority of the volatile substances.
• Oil content can be measured by NMR using AOCS Method AM 2-93 and AOCS Recommended Practice AK 4-95 or by near infra-red reflectance spectroscopy (NIR) using AOCS Method AK 3-94 and AOCS Procedure AM 1-92.
• Oil composition can be analyzed by extracting fatty acids from bulk seed samples (e.g., at least 10 seeds). Fatty acid TAGs in the seed are hydrolyzed and converted to fatty acid methyl esters. Percentages of fatty acids typically are designated on a weight basis and refer to the percentage of the fatty acid methyl ester in comparison with the total fatty acid methyl esters in the sample being analyzed.
• Seeds having an altered fatty acid composition may be identified by techniques known to the skilled artisan, e.g., gas-liquid chromatography (GLC) analysis of a bulked seed sample, a single seed or a single half-seed.
• LLC gas-liquid chromatography
• Half-seed analysis is well known in the art to be useful because the viability of the embryo is maintained and thus those seeds having what appears to be a desired fatty acid profile may be planted to form the next generation.
• bulk seed analysis typically yields a more accurate representation of the fatty acid profile of a given genotype.
• Fatty acid composition can also be determined on larger samples, e.g., oil obtained by pilot plant or commercial scale refining, bleaching and deodorizing of endogenous oil in the seeds.
• the following examples are to be construed as merely illustrative of how one skilled in the art can make and use the DAGAT gene fragments, and does not limit the scope of the invention described in the claims.
• Example 1 Cloning of a Brassica Acyl Transferase: A mouse acyl CoA:diacylglycerol acyltransferase (DAGAT) gene was recently identified (Case et al., Proc Natl Acad Sci USA 95:13018-13023, 1998). The deduced mouse DAGAT amino acid sequence was used to search for similar plant sequences in GenBank and dbEST databases. The mouse DAGAT protein sequence aligned with significant sequence identity and similarity to a putative Arabidopsis thaliana acyl- CoA:cholesterol acyltransferase (ACAT; GenBank Accession No. 3135276, locus ATAC003058). However, upon aligning the A.
• ACAT Arabidopsis thaliana acyl- CoA:cholesterol acyltransferase
• the 5' DAGAT- 1 primer had the sequence caucaucaucauACTGCCATGGACAGGTGTGATTCTGCTTTTT TATCA (SEQ ID NO:l), and the 3' DAGATD2 primer had the sequence cuacuacuacuaCTAGAGACAGGGCAATGTAGAAAGTATGTA (SEQ ID NO:2).
• Lowercase sequences were used for cloning into the pAMPl vector (Gibco, BRL).
• PCR amplification using DAGAT- 1 and DAGAT-2 primers was carried out as follows.
• Each lOO ⁇ l PCR reaction mixture contained 50ng of genomic DNA, 200 ⁇ M of each dNTP, IX buffer B (Gibco BRL), 1 ⁇ M DAGAT- 1 primer, 1 ⁇ M DAGAT-2 primer, 3mM magnesium sulfate, and 2 ⁇ l Elongase enzyme (Gibco BRL).
• the reaction mixture was denatured at 94°C for 3 minutes, followed by 30 cycles of denaturation at 94°C for 1 minute, annealing at 50°C for 2 minutes, and extension at 72°C for 3 minutes. A final extension incubation was performed at 72°C for 10 minutes after cycling. Based on the sequence of A. thaliana genomic DNA in
• GenBank Accession No. 3135276, a 1369 bp fragment was expected to be amplified from Brassica.
• FIG. 1 contains a restriction map of the pAMPl vector containing the putative DAGAT fragment, which has been designated pMB143.
• the partial sequence of the 5' end using the T7 primer was ACTTGCATTGTGTGGCTGAAGTTGGTTTCTTACGCTCATACTAACTATGAC ATAAGAACCCTAGCTAATTCATCTGATAAGGTAAAAGAAGTGATATAATA TTGGTCACTTGCATTGTGTTTTACTATTTTGACCAGACACTGTTGAAAACT GTAGGCCAATCCTGAAGTCTCCTACTATGTTAGCTTGAAGAGCTTGGCGTA TTTCATGCTTGCTCCCACATTGTGTTATCAGGTAATCTGATGCGTCTTCTGC TAATTGTATCATACATTATCTTTCACTTGCAAAAGTTTCTTGTCTAAAACCT TGCGTCTTCGCTTTACCCAGCCGAGCTATCCACGTTCT (SEQ ID NO:3).
• the partial sequence of the 3' end using the Sp6 primer was ATC AATCTTGTCTTACTC A A AAATCATATTATGTTTACGTTANTAACCAAA ATTCATGTACGCACTGTCTACCTTTGTCAGTATTGGAGAATGTGGAATATG GTATGGTTCTCTTCTTGAACATCCCCTTCTTTTTATACAAAGCAGATTAA GAAAAGCTTATTGAGATCTTGTTTTTTCTAATAGCCTGTTCATAAATGGAT GGTTCGACATGTATACTTTCCGTGCCTTCGCAGAAATATACCGAAAGTGA GTGTAGTTAATTGCGATGATCGATATTTTTTTCTGTGCTTCATAAATTTA AC CCTCCACTCATTTTTTTCCAGGTACCCGCTATTATCCTTGCTTTCTTAGTCT CTGCAGTCTTTCATGAGGTATAATACATACTTTCTACATTGNCCCTGTCTC (SEQ ID NO:4).
• the sequence of the B. napus clone obtained using the T7 primer had an overall identity of 76.5% with the corresponding region of the A. thaliana gene, suggesting that the 1.4 kb cloned B. napus fragment encoded a protein that may be related to the A. thaliana DAGAT or ACAT.
• Plasmid pMB143 will be deposited with the American Type Culture Collection (ATCC), 10801 University Boulevard., Manassas, VA, 201 10-2209.
• ATCC American Type Culture Collection
• Antisense DAGAT The putative DAGAT genomic DNA cloned in pAMPl was excised with a Smal/SnaBl digestion. The putative DAGAT fragment was purified and inserted at the blunted, EcoRl site of pMBl 10 to generate pMBl 71. This construct contains cruciferin promoter and cruciferin termination sequences. The antisense orientation of the putative DAGAT insert in pMB171 was confirmed with restriction analysis.
• the cruciferin promoter/putative DAGAT/cruciferin termination cassette was released from pMB171 by partially digesting with Xbal and completely digesting with Xhol, and cloned into the Xhol/Xbal sites of pMOG800 to generate pMB 170.
• Figure 2 provides a diagram of pMB 170.
• the construct pMB 170 was used to transform Agrobacterium LBA4404.
• Oil, protein, chlorophyll, glucosinolate, oleic acid (18: 1 ), linoleic acid (18:2), and ⁇ -linolenic acid (18:3) content were determined in the T2 seed samples.
• Oil content was measured by NIR using a Foss NIR Systems model 6500 Feed and Forage Analyzer (Foss North America, Eden Prairie, MN) calibrated according to manufacturer's recommendations.
• Canola seed samples which represented wide ranges of the sample constituents listed above, were collected for calibration.
• Lab analysis results were determined using accepted methodology (i.e., oil, AOCS Method Ak 3-94; moisture, AOCS Method Ai 2-75; fatty acid, AOCS Method CE le-91 and AOCS Method CE 2-66; chlorophyll, AOCS Method CC 13D-55; protein, AOCS Method BA 4e-93; and glucosinolates, AOCS Method Ak 1-92). Instrument response also was measured for each sample. A calibration equation was calculated for each constituent by means of chemometrics. These equations are combined into one computer file and are used for prediction of the constituents contained in unknown canola samples. T2 seed samples containing unknown levels of the above constituents were prepared by removing foreign material from the sample.
• T2 seeds from each of the ten selected plants were planted, and a nickel size portion of the leaf tissue was taken from plants about 2.5 weeks post-germination.
• Tissue samples were dried in a food dehydrator at 135°C for 8-16 hours.
• DNA was isolated using the Qiagen Dneasy96 Plant Kit, and resuspended in 150 ⁇ l of buffer.
• PCR amplification was performed in a 20 ⁇ l volume containing IX PCR buffer containing 1.5mM MgCl 2 (Qiagen PCR Core Kit), 0.2mM dNTP, 0.5 units Taq polymerase (Qiagen), 0.5 ⁇ M cruciferen primer (5'-CTT TAT GGA TGA GCT TGA TTG AG-3', SEQ ID NO:5), and 0.5 ⁇ M acyltransferase primer (5'-CCG CTC TAG AGG GAT CCA AGC-3', SEQ ID NO:6), 0.4% sucrose, and 0.008% cresol.
• IX PCR buffer containing 1.5mM MgCl 2 (Qiagen PCR Core Kit), 0.2mM dNTP, 0.5 units Taq polymerase (Qiagen), 0.5 ⁇ M cruciferen primer (5'-CTT TAT GGA TGA GCT TGA TTG AG-3', SEQ ID NO:5), and 0.5 ⁇ M acyltransferase
• Amplification conditions included 30 cycles of denaturation at 94°C for 30 seconds, annealing at 55°C for 30 seconds, and extension at 72°C for 1 minute. PCR products were analyzed 1.2% agarose gel electrophoresis. As indicated in Table 1, the selected plants tested positive for the transgene.

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Genetics & Genomics (AREA)
• Chemical & Material Sciences (AREA)
• Engineering & Computer Science (AREA)
• Zoology (AREA)
• Biotechnology (AREA)
• Organic Chemistry (AREA)
• Wood Science & Technology (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Molecular Biology (AREA)
• Biomedical Technology (AREA)
• General Engineering & Computer Science (AREA)
• General Health & Medical Sciences (AREA)
• Biochemistry (AREA)
• Microbiology (AREA)
• Nutrition Science (AREA)
• Plant Pathology (AREA)
• Biophysics (AREA)
• Physics & Mathematics (AREA)
• Cell Biology (AREA)
• Oil, Petroleum & Natural Gas (AREA)
• Medicinal Chemistry (AREA)
• Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
• Micro-Organisms Or Cultivation Processes Thereof (AREA)
• Enzymes And Modification Thereof (AREA)

Applications Claiming Priority (3)

Publications (1)

Family

ID=22453962

Family Applications (1)

Country Status (4)

Families Citing this family (16)

Family Cites Families (9)

• 2000
  • 2000-05-04 CA CA2372632A patent/CA2372632C/en not_active Expired - Fee Related
  • 2000-05-04 AU AU47034/00A patent/AU784352B2/en not_active Ceased
  • 2000-05-04 EP EP00928864A patent/EP1173583A1/de not_active Withdrawn
  • 2000-05-04 WO PCT/US2000/012316 patent/WO2000066749A1/en active Application Filing

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events